Cell Separation Technologies Market By Technology (Gradient centrifugation, Surface Markers Separation, Fluorescence Activated Cell Sorting, and Magnetic Cell Sorting), By Application (Oncology Research, Neuroscience Research, Stem Cell Research, and Microbiology & Immunology Research), and By Region - Trends, Analysis and Forecast till 2034

Cell Separation Technologies Market was valued at USD 8.92 Billion in 2024 and is projected to grow at a CAGR of 11.60 % to reach USD 26.5 Billion by 2034.

Cell separation technology is used to separate cells from groups of different cells. Cells are divided into different categories, based on their physical characteristics, such as size, shape, and protein expression.  Techniques for separating cells are crucial in the treatment of chronic illnesses like cancer and AIDS. Depending on the type of cells that need to be separated, a particular cell separation technology is employed.

The rapid rise in the cell therapy-based research activities have become key factor in the growth of the Cell Separation Technologies Market. The improving healthcare infrastructure and the rise in the prevalence of chronic diseases has given rise to demand for market growth. Further, the rise in the geriatric population and rapid surge in the investments in research and development activities has also become the major contribution in Cell Separation Technologies Market growth.

Increase in Prevalence of Chronic Diseases to Drive the Global Market

Increased sedentary lifestyle, ageing of the global population, increase in alcohol consumption, and increase in cigarette smoking are all contributing factors to the growth of chronic diseases like diabetes, obesity, arthritis, heart disorders, and cancer and that in turn have become the major factor in Cell Separation Technologies Market growth. The increase in cellular research activities is also propelling the growth of Cell Separation Technologies Market.

• For instance, in September 2020, according to World Health Organization (WHO) and the Non-communicable Disease (NCD) Alliance which was led by Imperial College London, it is said that chronic diseases are estimated to kill almost 41 million people a year across worldwide, constituting seven out of ten deaths globally. Out of these deaths roughly 17 million are classified as premature which are significantly younger than the expected age.  

Surge in Geriatric Population

The geriatric population is more inclined to suffer than the younger population to suffer from chronic illnesses like cancer and neurological disorders. Furthermore, compared to the younger population, the geriatric population is growing rapidly. The prevalence of cancer and Alzheimer's disease is expected to rise when there is an increase in population aged 65 years and above, which in turn, is anticipated to boost the growth of Cell Separation Technologies Market. The rise in demand for clinical trials and research is also fueling the growth of the target market.

• For instance, in October 2022, according to World Health Organization (WHO), 1 in 6 people in the world will be 60 years or older by 2030. The population of age group 60 and above will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will be doubled (2.1 billion). Between 2020 and 2050, the number of individuals aged 80 or older is projected to treble, reaching up to 426 million.

Restrains:

Research in cell biology is expensive since it needs to sustain strict standards and follow legal requirements. To get accurate outcomes, the study needs top-notch equipment, reagents, and other supplies. Furthermore, due to increased budgetary constraints, it is difficult for several institutions and small-scale biotechnology and biopharmaceutical companies to acquire expensive supplies for cell separation and that would subsequently limit the expansion of the target market. The undeveloped infrastructure and low healthcare expenditure would further, limit the growth of Cell Separation Technologies Market. 

Cell Separation Technologies Market is segmented based on Technology, Application and Region.

Technology Insight

On the basis of Technology, Cell Separation Technologies Market is segmented into Gradient centrifugation, Surface Markers Separation, Fluorescence Activated Cell Sorting, and Magnetic Cell Sorting. Gradient centrifugation segment is expected to dominate the target market growth due to the extensive usage of this technique by academic institutes, research laboratories, and biotechnology and biopharmaceutical companies. Centrifugation is one of the most important steps in the process. Density gradient centrifugation and differential centrifugation are primarily used in cell isolation and separation procedures.

Application Insights

On the basis of Application, Cell Separation Technologies Market is segmented into Oncology Research, Neuroscience Research, Stem Cell Research, and Microbiology & Immunology Research. Stem Cell Research segment are expected to dominate the target market growth as the use of stem cell therapy in the management of various carcinomas and other chronic disorders has greatly increased. Medical researchers can gain a deeper understanding of how chronic health disorders emerge by utilizing cell separation technologies in stem cell research. Many countries have increased their investment in stem cell research as a result of recognizing the potential of the stem cell therapy.

Regional Insights:

On the basis of region, the Cell Separation Technologies Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to factors such as the presence of well-established pharmaceutical & biotech industries and the high adoption of technologically advanced solutions in the U.S. Additionally, numerous research initiatives by academic institutions in the area of cell therapies, the widespread occurrence of infectious and chronic disorders, particularly the COVID-19 outbreak are anticipated to increase demand for cell separation technologies in the region.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Cell Separation Technologies Market report based on Technology, Application, and Region:

Cell Separation Technologies Market, By Technology:

• Gradient centrifugation
• Surface Markers Separation
• Fluorescence Activated Cell Sorting
• Magnetic Cell Sorting

Cell Separation Technologies Market, By Application:

• Oncology Research
• Neuroscience Research
• Stem Cell Research
• Microbiology & Immunology Research

Cell Separation Technologies Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Cell Separation Technologies Market includes, Mitenyi Biotec GmbH, BD Biosciences, Systems and Reagents, Inc., STEMCELL Technologies Terumo BCT, Inc., pluriSelect GmbH, EMD Millipore Corp., and Life Technologies, Inc.

• In 19 April 2022, Applied Cells Inc., a supporting industry expert across the globe in Cell Therapy Development and Tumor Detection and STEMCELL Technologies Canada Inc., a company that provides high-quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources to scientists announced their collaboration to deliver a new high-performance cell separation solution that combines Applied Cells' MARS® platform with STEMCELL's EasySep™ immunomagnetic cell separation kits. This collaboration would help researchers around the world to automate and increase the efficiency of isolating high-quality cells from a wide range of sample types such as whole blood, bone marrow, apheresis products, and dissociated tissue.
• In May 2023, Becton, Dickinson and Company, a leading global medical technology company launched World's First Spectral Cell Sorter known as “FACSDiscover™ S8” Cell Sorter. It enables researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments. Researchers can observe detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time. With the help of BD SpectralFX™ Technology, researchers can achieve full-spectrum cell sorting, coupled with expanded performance that is enabled by a new modular optical architecture and system-aware algorithms, to perform high-parameter experiments within a simplified workflow.

• Mitenyi Biotec GmbH
• BD Biosciences
• Systems and Reagents, Inc.
• STEMCELL Technologies Terumo BCT, Inc.
• pluriSelect GmbH
• EMD Millipore Corp.
• Life Technologies, Inc.